Docci D, del Vecchio C, Salvi P, Turci F, Salvi G, Cenciotti L, Pretolani E
Clin Nephrol. 1985 Feb;23(2):68-73.
The possible relationship between erythrocyte (RBC) function and secondary hyperparathyroidism (HPT) was examined in 35 uremic patients on maintenance hemodialysis. Mechanical tests (i.e., osmotic fragility and deformability) were used to assess RBC function. Secondary HPT was evaluated by means of serum biochemistry (parathyroid hormone, calcium, phosphorus, and alkaline phosphatase) and radiographic examinations (X-ray films of the hand skeleton). Sixteen sex and age-matched normal volunteers acted as controls. This study shows that the mechanical properties of RBC were indeed markedly altered in hemodialysis patients when compared with controls. No significant correlations between either the osmotic fragility or the deformability of RBC and the hematochemical changes associated with secondary HPT were found. No differences in RBC function tests were found as far as the activity (alkaline phosphatase) or the severity (X-ray findings) of secondary HPT are concerned. Effective treatment of secondary HPT by either pharmacological means (1,25-dihydroxycholecalciferol) or surgical removal was not associated with consequent improvement in RBC function. These findings clearly speak against secondary HPT as a major cause of RBC dysfunction in uremic patients on maintenance hemodialysis.
在35例维持性血液透析的尿毒症患者中,研究了红细胞(RBC)功能与继发性甲状旁腺功能亢进(HPT)之间的可能关系。采用机械测试(即渗透脆性和变形性)来评估RBC功能。通过血清生化检查(甲状旁腺激素、钙、磷和碱性磷酸酶)和影像学检查(手部骨骼X线片)来评估继发性HPT。16名年龄和性别匹配的正常志愿者作为对照。本研究表明,与对照组相比,血液透析患者的RBC机械性能确实发生了显著改变。未发现RBC的渗透脆性或变形性与继发性HPT相关的血液化学变化之间存在显著相关性。就继发性HPT的活性(碱性磷酸酶)或严重程度(X线表现)而言,RBC功能测试未发现差异。通过药物治疗(1,25-二羟胆钙化醇)或手术切除对继发性HPT进行有效治疗,并未使RBC功能随之改善。这些发现明确表明,继发性HPT并非维持性血液透析尿毒症患者RBC功能障碍的主要原因。